BRIEF published on 08/09/2024 at 07:50, 2 years 1 month ago Eckert & Ziegler Achieves Significant Growth in First Half of 2024 Sales Increase Financial Forecast Earnings Growth Medical Segment Isotope Products
BRIEF published on 08/09/2024 at 07:50, 2 years 1 month ago Eckert & Ziegler réalise une croissance significative au premier semestre 2024 Prévisions Financières Croissance Des Bénéfices Augmentation Des Ventes Secteur Médical Produits Isotopiques
PRESS RELEASE published on 08/09/2024 at 07:45, 2 years 1 month ago Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024 Eckert & Ziegler SE reports continued sales and earnings growth in the first half of 2024. Sales up by 23% to €145.4 million, EBIT rose to €32.5 million Financial Results Sales Growth 2024 Earnings Growth Eckert & Ziegler SE
BRIEF published on 08/05/2024 at 15:50, 2 years 1 month ago Eckert & Ziegler Expands GalliaPharm® Availability Across EEA Nuclear Medicine GalliaPharm® EEA Approval Radionuclide Generators Cost-effective Diagnostics
BRIEF published on 08/05/2024 at 15:50, 2 years 1 month ago Eckert & Ziegler étend la disponibilité de GalliaPharm® dans l'EEE Médecine Nucléaire GalliaPharm® Approbation EEE Générateurs De Radionucléides Diagnostics Rentables
PRESS RELEASE published on 08/05/2024 at 15:45, 2 years 1 month ago Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE extends availability of GalliaPharm® to the entire European Economic Area after receiving EC approval, offering cost-effective radiolabeling solution for PET diagnostics Eckert & Ziegler SE European Economic Area GalliaPharm® EC Approval Radiolabeling
BRIEF published on 07/16/2024 at 14:31, 2 years 2 months ago Eckert & Ziegler Increases Sales and Earnings, Raises Profit Forecast for 2024 Sales Growth Eckert & Ziegler EBIT Profit Forecast 2024 Financial Results
BRIEF published on 07/16/2024 at 14:31, 2 years 2 months ago Eckert & Ziegler augmente ses ventes et ses bénéfices et relève ses prévisions de bénéfices pour 2024 Eckert & Ziegler EBIT Prévisions De Bénéfices La Croissance Des Ventes Résultats Financiers 2024
PRESS RELEASE published on 07/16/2024 at 14:26, 2 years 2 months ago EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. Eckert & Ziegler SE reports impressive sales and earnings growth in the first half of 2024. Profit forecast raised for 2024 Sales Growth Earnings Increase Profit Forecast Eckert & Ziegler SE 2024 Financial Results
BRIEF published on 06/26/2024 at 16:32, 2 years 2 months ago Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG Annual General Meeting Dividend Eckert & Ziegler Pentixapharm AG Corporate Split-Off
Published on 09/23/2026 at 02:00, 1 hour 5 minutes ago Battery X Metals Announces up to $1 Million Private Placement Financing to Advance Corporate Growth Initiatives
Published on 09/23/2026 at 00:00, 3 hours 5 minutes ago Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/23/2026 at 00:00, 3 hours 5 minutes ago Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/22/2026 at 23:10, 3 hours 55 minutes ago Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 19:40, 7 hours 24 minutes ago EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 8 hours 5 minutes ago LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 8 hours 19 minutes ago MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 8 hours 35 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 8 hours 35 minutes ago Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)
Published on 09/22/2026 at 18:00, 9 hours 5 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 9 hours 5 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 9 hours 20 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 9 hours 20 minutes ago Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026
